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AbSTRACT
Introduction: chikungunya fever is a viral disease caused by an alphavirus from the to-
gaviridae family, that is transmitted by mosquitoes of the genus Aedes. it is manifested by 
fever, skin rash and joint pain. A high percentage of patients develop a persistent polyar-
thritis that can last for months or even years.   
objectives: to describe the clinical and epidemiological characteristics of patients diag-
nosed with arthritis after chikungunya fever. 
 Materials and methods:  A retrospective, cross-sectional study of patients who were seen 
at the District Hospital of Villa Elisa during the first semester of 2015, and were diagnosed 
with chikungunya fever.  
Results: A total of 26 patients from Asunción were included, of which 92% were women, 
with an average age of 47.2 years. the predominant symptoms were arthralgia (92.3%) 
and headache (76.9%). Joint symptoms started on average 14 days after the onset of 
fever. the proximal metacarpophalangeal and interphalangeal joints were affected in 73% 
of the patients, the radiocarpal and knee joints in 76.9%, shoulders in 50% and feet in 92.3%. 
All patients were treated with nSAiDs and 76.9% received treatment with prednisone, with 
partial or total improvement of symptoms in 92.3% of the cases. two patients (7.6%) re- 
quired Methotrexate due to the persistence of arthritis after corticosteroids were discontin-
ued.  
Conclusion: chikungunya fever is a major health issue in our country, especially due to 
its ability to generate rheumatological complications in the medium and long run. We must 
pay special attention to this pathology since the chronic joint compromise can lead to 
disability and labor absenteeism, which would translate into overload of the public health 
system.  
RESUMEN
CoMPRoMISo ARTICUlAR DESPUÉS
FIEbRE CHIKUNGUNYA EN UN HoSPITAl DE SEGUNDo NIVEl 
DURANTE lA EPIDEMIA 2015. ASUNCIóN, PARAGUAY
Introducción: La fiebre de Chikungunya es una enfermedad viral causada por un alfa-
virus de la familia Togaviridae, que se transmite por los mosquitos del género Aedes. Se 
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milar to those of any infection by the togaviridae fam-
ily1,2 and the are listed in order of frequency in table 1.
 Articular  compromise has a particular characteris-
tic in this infection. A significant percentage of patients 
have persistent pain and joint inflammation beyond the 
acute febrile period, in some cases becoming chronic, 
lasting for months or even years. in these cases, the dis- 
ease leaves the infectious field to enter the spectrum 
INTRoDUCTIoN
 
 chikungunya fever is a viral disease, recently intro-
duced to the American continent, that became a bigger 
threat than those already existing in the group of viral 
diseases transmitted by mosquitoes1. the WHO de-
fines Chikungunya fever (CHIK) as an emerging disease 
transmitted by Aedes aegypti and albopictus mosqui- 
toes, which are the same species involved in the trans-
mission of dengue. it is caused by a virus of the al-
phavirus genus (cHiKv) that is native to the African 
continent. in the last decade, however, the disease 
has evolved epidemiologically, and expanded its geo-
graphic range throughout the Americas, becoming a 
threat not only to Africa but to our continent as well1,2. 
in general, the epidemies caused by this virus are 
characterized by a cyclical presentation, with periods 
of 4 to 30 years. Paraguay has been an endemic coun-
try for Dengue virus for several years. Both vectors of 
the Aedes genus are found in our territory, each of them 
capable of transmitting cHiK and Dengue. the ease 
of dissemination due to the abundance of vectors has 
made containment of the disease an arduous task for 
health authorities2. The first Chikungunya fever cases 
reported in Paraguay, were imported from tourists who 
visited endemic areas in central America. in February 
2015, the detection of 8 autochthonous cases in the Ko-
cue guazú neighborhood of the Fernando de la Mora 
marked the arrival of the cHiKv to the country. the clini- 
cal manifestations of acute infection with cHiKv are si-
manifiesta por fiebre, erupción cutánea y dolor en las articulaciones. Un alto porcentaje 
de pacientes desarrolla una poliartritis persistente que puede durar meses o incluso años.
objetivos: describir las características clínicas y epidemiológicas de los pacientes diag-
nosticados de artritis después de la fiebre de Chikungunya.
Materiales y métodos: Estudio retrospectivo, transversal, de pacientes que fueron aten-
didos en el Hospital de Distrito de villa Elisa durante el primer semestre de 2015 y fueron 
diagnosticados con fiebre de Chikungunya.
Resultados: Se incluyeron un total de 26 pacientes de Asunción, de los cuales el 92% eran 
mujeres, con una edad promedio de 47,2 años. Los síntomas predominantes fueron artral-
gia (92.3%) y cefalea (76.9%). Los síntomas articulares comenzaron en promedio a los 14 
días después de la aparición de la fiebre. Las articulaciones metacarpofalángicas proxi-
males e interfalángicas se vieron afectadas en el 73% de los pacientes, las articulaciones 
radiocarpales y de rodilla en el 76,9%, los hombros en el 50% y los pies en el 92,3%. todos 
los pacientes fueron tratados con AinE y 76.9% recibieron tratamiento con prednisona, con 
mejoría parcial o total de los síntomas en 92.3% de los casos. Dos pacientes (7,6%) requi-
rieron Metotrexato debido a la persistencia de la artritis después de que se interrumpieron 
los corticosteroides.
Conclusión: La fiebre de Chikungunya es un importante problema de salud en nuestro 
país, especialmente por su capacidad de generar complicaciones reumatológicas a media- 
no y largo plazo. Debemos prestar especial atención a esta patología ya que el compromi-
so conjunto crónico puede conducir a la discapacidad y el ausentismo laboral, lo que se 
traduciría en una sobrecarga del sistema de salud pública.
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Table 1 clinical Manifestations of chikungunya Fever.
Signs / symptoms 
Fever
Polyarthralgia
Headaches
Myalgia
Back pain
nausea
vomit
rash 
Polyarthritis
conjunctivitis
Frequency %
76-100
71-100
17-74
46-72
34-50
50-69
4-59
28-77
12-32
3-56
Source: taken from PAHO / WHO / cDc. Preparation and response to 
the eventual introduction of the chikungunya virus in the Americas1.
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performed with the SPSS program version 19.0. the 
qualitative variables were expressed as frequencies 
and percentages, while the quantitative variables were 
averaged.
RESUlTS
 From the total visits to the rheumatology office, dur-
ing the study period, a total of 26 patients with joint 
symptoms after chikungunya fever were identified. The 
epidemiological and clinical characteristics obtained 
are described in the following 2 tables.
Joint involvement was found in 24/26 (92.3%) patients. 
Arthralgias without arthritis were present in 4/24 (16, 
6%) patients and 20/24 (83.3%) had frank arthritis. the 
distribution of joint involvement, is described in table 4. 
All patients received therapy with non-steroidal anti-
inflammatory drugs, 20/26 (76, 9%) also received 
low doses of prednisone and in 2/26 (7.6%) patients 
Methotrexate was added due to persistent arthritis 
after discontinuation of corticosteroids.
DISCUSSIoN
 the predominant symptom in our group of patients 
was joint involvement. Arthralgias and / or arthritis, was 
found in 83.3% of the patients, which was somewhat 
higher than previous reports1.
 Joint symptoms occurred on average 14 days 
after the  fever began. the most affected joints were the 
feet (tarsus and ankles), followed by the knees, wrists, 
metacarpophalangeal and proximal interphalangeal 
joints and shoulders. These findings were very simi-
lar to what is cited in other studies3,4. Among patients 
diagnosed with arthritis after cHiKv, 76.9% received 
prednisone, mostly due to persistent arthritis, despite 
treatment with nSAiDs.
 in the majority, low doses of corticosteroids were 
administered for a short period of time. However, other 
patients required high doses of prednisone at the 
beginning (up to 40 mg / day) due to the significant 
joint involvement translated by considerable functional 
disability. All of them were weaned to minimal doses 
progressively over the course of two weeks.  
 Since there are no standardized treatment guide-
lines and little is known about the efficacy of antiviral 
treatment in the acute and chronic phase8, treatment 
is usually extrapolated from the management of other 
of chronic joint pathologies, and the participation of the 
rheumatologist becomes essential for the management 
of the patients. Our objective is to describe the clinical 
and epidemiological characteristics of patients diag-
nosed with post-chikungunya fever arthritis treated in a 
public care center in Asunción and surrounding areas.
MATERIAlS AND METHoDS 
 A retrospective, cross sectional study of patients 
diagnosed with chikungunya fever at District Hospi-
tal of villa Elisa, greater Asunción, during the cHiK 
epidemic from February to July 2015 was carried out. 
the clinical and demographic characteristics were 
described, as well as treatment and patient outcomes. 
Arthritis and arthralgias were defined based on clinical 
criteria as assessed by a rheumatologist and the diag-
nosis of chikungunya fever was made based on serol-
ogy or epidemiological link. the statistical analysis was 
Table 2 Epidemiological characteristics.
Epidemiological characteristics
Age (in years)
 Sex:  
Female (%)
Male (%)
Location: great Asuncion
Values
47,2
24/26 (92%)
2/26 (8%)
26/26 (100%)
Table 3 clinical characteristics.
Signs / symptoms
Fever duration (in days)
Articular involvement  (%)
Skin rash(%)
Headache (%)
Duration of skin rash (in days)
Values
2,86
24/26 (92,3%)
24/26 (92,3%)
20/26 (76,9%) 
4,5
Table 4 characteristics of joint involvement.
Committed joints
Feet (tarsal and ankles)
radiocarpal
Knees
Metacarpophalangeal 
and interphalangeal 
Shoulders
Values n%
24/26 (92,3%)
20/26 (76,9%)
20/26 (76,9%)
19/26 (73%)
13/26 (50%)
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diseases. Partial or total improvement of symptoms 
occurred in the majority of our patients (92.3%). How-
ever, 2 patients had to receive Methotrexate due to 
persistence of arthritis and inability to wean off steroid, 
thus entering the group of chronic inflammatory rheuma- 
tism (cir). interestingly, the number of patients with 
post-cHiKv cir in this study is somewhat lower than 
that of other countries. in colombia, according to some 
studies, aprox 3 million cases were detected between 
2014 and 2015, and close to 50% were affected with 
or were at risk for post cHiKv5  cir. this work found 
similar trends to the first publications of large popula-
tions in Reunion Island, in which a significant percent- 
age of patients with cHiK progressed  to chronic joint 
or musculoskeletal symptoms6. Another interesting fact 
in this study was that all patients received treatment 
with non-steroidal anti-inflammatory drugs, whether 
due to joint pain or soft-tissue pain or headache. the 
most commonly prescribed antinflammatory was di-
clofenac alone or in combination with paracetamol, 
in agreement with treatment recommendations of the 
Ministry of Public Health and Social Welfare2,7. the 
average duration of the acute febrile episode in these 
patients was approximately 3 days, a rather short 
period in comparison with other arboviruses1.2. A signif-
icant percentage of patients presented with skin rash 
(92.3%), a finding described as more characteristic in 
infections by other viruses such as Zika or dengue than 
in patients with chikungunya fever. the rash lasted an 
average of 4.5 days. 
CoNClUSIoN
 chikungunya fever represents a major public health 
problem, due to its ability to generate rheumatologi-
cal complications in the medium and long run. Spe-
cial attention must be paid this pathology, in view of 
the abundance of vectors in our country, the ease of 
dissemination and to the overlap with other infectious 
diseases prevalent in our environment such as dengue 
or Zica. Although chronic inflammatory compromise of 
the joints was not very common in this study, it can 
have an important impact on patients’ quality of life, 
with variable degrees of disability, predisposing to 
work absenteeism.
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